Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)
Titel:
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)
Auteur:
Haddad, Tufia C. He, Jun O’Sullivan, Ciara C. Chen, Beiyun Northfelt, Donald Dueck, Amylou C. Ballman, Karla V. Tenner, Kathleen S. Linden, Hannah Sparano, Joseph A. Hopkins, Judith O. De Silva, Chamath Perez, Edith A. Haluska, Paul Goetz, Matthew P.